NM_021072.4:c.24C>T

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_021072.4(HCN1):​c.24C>T​(p.Asn8Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000252 in 1,354,734 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00027 ( 0 hom. )

Consequence

HCN1
NM_021072.4 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 2.32

Publications

0 publications found
Variant links:
Genes affected
HCN1 (HGNC:4845): (hyperpolarization activated cyclic nucleotide gated potassium channel 1) The membrane protein encoded by this gene is a hyperpolarization-activated cation channel that contributes to the native pacemaker currents in heart and neurons. The encoded protein can homodimerize or heterodimerize with other pore-forming subunits to form a potassium channel. This channel may act as a receptor for sour tastes. [provided by RefSeq, Oct 2011]
HCN1 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 24
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • generalized epilepsy with febrile seizures plus
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • generalized epilepsy with febrile seizures plus, type 10
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 5-45696070-G-A is Benign according to our data. Variant chr5-45696070-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 461372.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.32 with no splicing effect.
BS2
High AC in GnomAd4 at 20 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HCN1NM_021072.4 linkc.24C>T p.Asn8Asn synonymous_variant Exon 1 of 8 ENST00000303230.6 NP_066550.2 O60741Q86WJ6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HCN1ENST00000303230.6 linkc.24C>T p.Asn8Asn synonymous_variant Exon 1 of 8 1 NM_021072.4 ENSP00000307342.4 O60741
HCN1ENST00000673735.1 linkc.24C>T p.Asn8Asn synonymous_variant Exon 1 of 9 ENSP00000501107.1 A0A669KB45
HCN1ENST00000634658.1 linkc.24C>T p.Asn8Asn synonymous_variant Exon 1 of 2 3 ENSP00000489134.1 A0A0U1RQR7

Frequencies

GnomAD3 genomes
AF:
0.000134
AC:
20
AN:
149496
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000243
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000284
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000399
AC:
3
AN:
75192
AF XY:
0.0000459
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000108
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000266
AC:
321
AN:
1205132
Hom.:
0
Cov.:
32
AF XY:
0.000241
AC XY:
143
AN XY:
593542
show subpopulations
African (AFR)
AF:
0.0000415
AC:
1
AN:
24106
American (AMR)
AF:
0.00
AC:
0
AN:
22574
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
18984
East Asian (EAS)
AF:
0.00
AC:
0
AN:
21366
South Asian (SAS)
AF:
0.00
AC:
0
AN:
63522
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
28288
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3618
European-Non Finnish (NFE)
AF:
0.000309
AC:
302
AN:
975986
Other (OTH)
AF:
0.000386
AC:
18
AN:
46688
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
17
35
52
70
87
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000134
AC:
20
AN:
149602
Hom.:
0
Cov.:
32
AF XY:
0.000123
AC XY:
9
AN XY:
72964
show subpopulations
African (AFR)
AF:
0.0000242
AC:
1
AN:
41300
American (AMR)
AF:
0.00
AC:
0
AN:
15066
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3424
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5086
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9666
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000284
AC:
19
AN:
66952
Other (OTH)
AF:
0.00
AC:
0
AN:
2082
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000285
Hom.:
0
Bravo
AF:
0.000132

ClinVar

Significance: Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Inborn genetic diseases Benign:1
Oct 23, 2019
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Developmental and epileptic encephalopathy Benign:1
Jun 15, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

HCN1-related disorder Benign:1
Mar 25, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
Jun 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

HCN1: BP4, BP7 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.63
CADD
Benign
12
DANN
Benign
0.92
PhyloP100
2.3
PromoterAI
-0.0033
Neutral

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs753690439; hg19: chr5-45696172; API